1. (a) A manufacturer of an investigational drug, biological product, or device may make available the investigational drug, biological product, or device to a qualified patient.

2. (b) A manufacturer may do any of the following:

   1. (1) Provide an investigational drug, biological product, or device to a qualified patient without receiving compensation.
   2. (2) Require a qualified patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device.

As added by P.L.2-2015, SEC.3.